Prospective, multicentre, randomised, double-blind, plac

Project: Research project

Description

Prospective, multicentre, randomised, double-blind, placebocontrolled, 2-parallel groups, phase 3 study to compare efficacy and safety of masitinib to placebo in the treatment of grade 2-3 non-resectable mast cell tumors in dogs not previously treated by
StatusFinished
Effective start/end date3/1/162/28/17

Funding

  • AB SCIENCES

Fingerprint

Mast Cells
Placebos
Dogs
Safety
Neoplasms
Therapeutics
masitinib